Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ahmed F. Massoud"'
Autor:
Yves Kockaerts, Louise E. Docherty, Deborah J G Mackay, I. Karen Temple, Andreas P. Haemers, Lise G. Larsen, Johanne M D Hahnemann, Vijith Puthi, Lutgarde Dooms, C. T. Bich Ngoc, Anna Lehmann, Carlo L. Acerini, Dũng Chí Vũ, Karen Grønskov, Pinar Dayanikli, Ahmed F. Massoud, Susanne E Boonen, Zeynep Tümer, Frida Sundberg, Phuong Bich Nguyen, Olga Kordonouri
Publikováno v:
Diabetes Care. 36:505-512
OBJECTIVE Transient neonatal diabetes mellitus 1 (TNDM1) is the most common cause of diabetes presenting at birth. Approximately 5% of the cases are due to recessive ZFP57 mutations, causing hypomethylation at the TNDM locus and other imprinted loci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93bc5d5da9493429f8b34b9137f765c5
https://doi.org/10.2337/dc12-0700
https://doi.org/10.2337/dc12-0700
OBJECTIVE: Hexarelin is a synthetic six-amino-acid compound capable of releasing GH in animals and in man. Its mechanism of action is not understood and little is known about the GH response after repeated administration. The aim of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4b8de1a670b7414a19047b27b50970c
https://ora.ox.ac.uk/objects/uuid:0cb45c98-7749-49d5-b89e-4367355f3dfb
https://ora.ox.ac.uk/objects/uuid:0cb45c98-7749-49d5-b89e-4367355f3dfb
Publikováno v:
European Journal of Endocrinology
ContextFamilial glucocorticoid deficiency (FGD) is a rare autosomal recessive disease, characterised by isolated glucocorticoid deficiency in the absence of mineralocorticoid deficiency. Inactivating mutations in the ACTH receptor (melanocortin-2-rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c60a270a4467871d4ae1eb7cb4f60f2e
https://doi.org/10.1530/eje-08-0636
https://doi.org/10.1530/eje-08-0636
Autor:
Susanne E, Boonen, Deborah J G, Mackay, Johanne M D, Hahnemann, Louise, Docherty, Karen, Grønskov, Anna, Lehmann, Lise G, Larsen, Andreas P, Haemers, Yves, Kockaerts, Lutgarde, Dooms, Dung Chí, Vu, C T Bich, Ngoc, Phuong Bich, Nguyen, Olga, Kordonouri, Frida, Sundberg, Pinar, Dayanikli, Vijith, Puthi, Carlo, Acerini, Ahmed F, Massoud, Zeynep, Tümer, I Karen, Temple
Publikováno v:
Diabetes Care
OBJECTIVE Transient neonatal diabetes mellitus 1 (TNDM1) is the most common cause of diabetes presenting at birth. Approximately 5% of the cases are due to recessive ZFP57 mutations, causing hypomethylation at the TNDM locus and other imprinted loci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d6e8b02bdb2249d86e741b769cd8b9c2
https://pubmed.ncbi.nlm.nih.gov/23150280
https://pubmed.ncbi.nlm.nih.gov/23150280
Autor:
Iain C. A. F. Robinson, Ahmed F. Massoud, Jamal Raza, Charles G. D. Brook, Peter C. Hindmarsh
Publikováno v:
Clinical endocrinology. 48(2)
OBJECTIVE This study evaluated the effect of corticotrophin-releasing hormone (CRH) on growth hormone releasing hormone (GHRH)-stimulated growth hormone (GH) release in man. DESIGN Six healthy adult volunteers (age 20–35 years) were studied. On dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c72cc5f33e1fba1f0fcfcf249b8974d7
https://pubmed.ncbi.nlm.nih.gov/9579235
https://pubmed.ncbi.nlm.nih.gov/9579235
Publikováno v:
Clinical endocrinology. 47(5)
OBJECTIVE Growth hormone releasing peptides (GHRPs) are potent growth hormone (GH) secretagogues. Their interaction with growth hormone releasing hormone (GHRH) has been studied extensively. Data on their interaction with somatostatin (SS) are limite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ac0b2041c44ad0882671dd41df12f7e
https://pubmed.ncbi.nlm.nih.gov/9425393
https://pubmed.ncbi.nlm.nih.gov/9425393
Publikováno v:
The Journal of clinical endocrinology and metabolism. 81(12)
Dose-response data for GH-releasing peptides are limited. We studied the effects of varying doses (0-1.0 microgram/kg) of hexarelin, a novel GH-releasing peptide, administered iv to healthy adult males on GH, PRL, and cortisol release. In addition, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b03015dfd6dbc8c4d613ee69665ad25
https://pubmed.ncbi.nlm.nih.gov/8954038
https://pubmed.ncbi.nlm.nih.gov/8954038
Publikováno v:
Clinical endocrinology. 43(5)
Summary OBJECTIVE Growth hormone releasing peptides (GHRPs) are a group of synthetic compounds capable of releasing GH by an unknown mechanism. The aim of this study was to determine the effect of administering biosynthetic human growth hormone (rhGH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8499c0532bdc339ecad849675125e74
https://pubmed.ncbi.nlm.nih.gov/8548947
https://pubmed.ncbi.nlm.nih.gov/8548947